INTRODUCTION
============

Shigatoxigenic *Escherichia coli* (STEC) emerged in the early 1980s as the causal agents of a variety of clinical symptoms and sequelae ranging from mild diarrhea through to life threatening conditions such as hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) ([@B1]). The most prevalent STEC strains in the UK, North America and Japan belong to the infamous O157:H7 serogroup ([@B2; @B3; @B4]), though several other serogroups dominate mainland Europe and South America ([@B5],[@B6]). The most notable non-O157 serogroups known to be strongly associated with human outbreaks are O26 ([@B7]), O111 ([@B8]) and O145 ([@B9]). STEC are characterized by carriage of numerous pathogenicity determinants, but it is the presence of Stx-phages, encoding the eponymous Shiga toxins (Stx) ([@B10],[@B11]), which is without doubt the primary factor responsible for the most serious disease manifestations. Significantly, these Stx-phages also have the ability to convert non-pathogenic, commensal bacteria into toxin producers, thus augmenting disease progression ([@B10],[@B12],[@B13]).

Stx-phages are classified as lambdoid and, as such, are characteristically temperate and encode an immunity system analogous to bacteriophage lambda ([@B14],[@B15]). Immediately after bacteriophage entry into a host cell, Stx-phage can follow either a lytic or lysogenic replication strategy, with the latter resulting in site-directed integration of the phage genome into the bacterial chromosome to generate a prophage, which later can be induced to enter the lytic replication route if exposed to an appropriate induction signal ([@B16]). Establishment of lysogeny requires bacteriophage expression of integrase (Int). Usually, the integrases encoded by lambdoid phages are tyrosine recombinases, which, during phage integration, form an Int/DNA intasome complex to catalyze unidirectional creation and resolution of a four way Holliday junction, ultimately yielding an integrated prophage ([@B17]). Integrase is the only phage-encoded protein required to facilitate this reaction. Once integrated, the lambdoid prophage produces a repressor (CI), which self-regulates its own promoter and inhibits all other phage gene expression in the lysogen plus any additional incoming homoimmune phage, thus maintaining stable lysogeny and precluding superinfection ([@B15]). However, contrary to expectations, various different Stx-phages have been described that are able to circumvent superinfection immunity at high frequency ([@B18],[@B19]). The Stx-phage, Φ24~B~, can integrate into a single host at least three times, consecutively, with increasing efficiency during each successive infection ([@B20]). Multiple infections of this nature may lead to amplified toxin production resulting from a greater *stx* gene copy number and increased opportunity for intracellular recombination with consequent evolutionary implications ([@B21],[@B22]). Φ24~B~ also encodes a putative antirepressor gene, *ant*, which shares 82% C-terminal identity to the archetypal antirepressor of the *Salmonella* bacteriophage P22 ([@B20]). Under normal conditions, the P22 antirepressor is not expressed and superinfection events are blocked, but under conditions that enable its expression, the P22 antirepressor binds and inactivates the P22 repressor protein, CII ([@B23; @B24; @B25]). Furthermore, the P22 Ant is also effective against the homologous λ repressor CI ([@B24]). This Ant-mediated repressor inactivation is a potential mechanism to explain the lack of superinfection immunity in Φ24~B~ ([@B20]).

Under certain conditions, such as DNA damage, an integrated phage may be induced to excise itself from the host genome and enter the lytic replication cycle. Activated RecA (part of the host SOS response) induces autocleavage of the repressor ([@B26]), allowing infective phage particles to be produced. Similarly to integration, bacteriophage excision is also catalyzed by integrase, though a phage-encoded excisionase is required additionally to control directionality of the reaction (Xis or recombination directionality factor, RDF) ([@B27],[@B28]). RDFs may control the fate of the integrase-catalyzed reaction by directly interacting with the intasome, facilitating an allosteric change which favors excision ([@B29]), or alternatively, they may act as transcriptional activators, inducing expression of their cognate integrases thereby promoting phage excision ([@B28]). In most cases, an RDF/Xis factor is necessary to enable excision of an integrated stretch of DNA. There is a single case, described in association with a pathogenicity island, where an integrase is able to catalyze integration and excision reactions, independent of a specific excisionase ([@B30],[@B31]), but this has never been described for an infective phage.

Preliminary qualitative RT--PCR data revealed that Stx-phage Φ24~B~ weakly expresses a putative antirepressor in uninduced lysogen cells ([@B20]). Moreover, these cells also unexpectedly express *int* indicating that integrase production may not be fully repressed in lysogen cells. These two observations support alternative hypotheses to explain establishment of multiple lysogeny by Stx-phages, antirepressor or integrase mediated, respectively. Here, we demonstrate increasing levels of Φ24~B~ integrase expression in multiple lysogen cultures and apparently negligible repression of *int* expression by CI. The Φ24~B~ *int* transcription start site and promoter region were determined and found to differ from *in silico* predictions ([@B20]). We also confirm activity of this integrase in the integration reaction but rule out the possibility that it can catalyze excision in the absence of a phage directionality factor, despite the absence of an obvious associated excisionase in the Φ24~B~ genome. Subsequently, we located a novel excisionase gene, identified through genetic complementation assays when co-expressed with Φ24~B~ *int*. In addition, the previous proposal of a putative antirepressor affect on superinfection immunity is revisited and a new hypothesis put forward.

MATERIALS AND METHODS
=====================

Bacterial strains, bacteriophages and media
-------------------------------------------

The bacterial strains, bacteriophages and plasmids used in this study are listed in [Table 1](#T1){ref-type="table"}. *Escherichia coli* K-12 strain MC1061 was the host of choice for bacteriophage infection and lysogen production. JM109-λ pir was the propagation strain for the suicide plasmid pKNG101, while Invitrogen One Shot TOP10 cells were used for all cloning and recombination assays, except where the plasmid pΦ24~B~-IX was used, which required the use of *E. coli* strain BL21(AI) to control the expression of excisionase under its inducible T7 promoter. Bacteria were routinely cultured in phage buffer \[2.5% (w/v) Luria--Bertani (LB) broth (Merck) with 0.01 M CaCl~2~\] or on LB agar plates \[2.5% LB broth plus 1.5% (w/v) agar (Merck)\]. Where appropriate, the following antibiotics were added (µg ml^−1^): rifampicin (3500), ampicillin (100), kanamycin (50), chloramphenicol (50) and spectinomycin (100). Table 1.Bacteria/phage strains and plasmids used in this studyStrain/PlasmidDescriptionReferencesMC1061*E. coli* K-12 derivative([@B83])DM1187*E. coli* K-12 derivative, *recA441*([@B84])JM109 λ pir*E. coli* K-12 derivative, λ pir([@B85])Φ24~B~::KanStx-phage, *stxA~2~Δaph3*([@B18])Φ24~B~::CatStx-phage, *stxA~2~Δcat*Φ24~B~::SpecStx-phage, *stxA~2~ΔaadA*([@B20])Φ24~B~::Kan *antΔ*Stx-phage, stxA~2~Δaph3, antΔaadAThis studyOneShot TOP10Competent cells, *recA-*InvitrogenBL21(AI)araB::T7RNAP-tetA, recA-pBAD/*Myc*-His CaraBAD, C-*myc*/His6 epitope, pBR322 ori, Am^R^pKNG101R6K Ori, *sacB*, Sm^R^([@B86])pACYC-DuetP15A ori, Cm^R^Novagen, EMDpCDF-DuetCDF ori, Sp/Sm^R^pΦ24~B~-*cI*pBAD carrying Φ24~B~*cI*This studypΦ24~B~-*int*pBAD carrying Φ24~B~*int*pΦ24~B~-*attB*pACYC-Duet carrying Φ24~B~*attB*pΦ24~B~-*attP*pCDF-Duet carrying Φ24~B~*attP*pΦ24~B~-*attBP*pΦ24~B~-*attP* integrated into pΦ24~B~-*attB*pΦ24~B~-XpACYC carrying Φ24~B~*xis*pΦ24~B~-IXpΦ24~B~-*int* carrying Φ24~B~*xis*pΦ24~B~-*ant*pBAD carrying Φ24~B~*ant*pKNG-*ant*pKNG101 carrying Φ24~B~*ant*pKNG-*antΔ*pKNG101 carrying Φ24~B~*antΔaadA*pStxACYCpACYC-Duet carrying Φ24~B~*pR′-luxABCDE* fusion[^2]

Antirepressor knockout
----------------------

The 'putative' Φ24~B~ antirepressor was amplified using Ant F/R primers ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)). The resulting PCR product and the suicide vector pKNG101 were cut with BamHI restriction endonucleases, agarose gel purified and recovered with the QIAquick gel extraction kit. The two purified DNA fragments were ligated together to produce pKNG-*ant* ([Table 1](#T1){ref-type="table"}). Selected transformants were used as a template for inverse PCR using Ant Inv F/R primers ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)), while the *aadA* spectinomycin resistance cassette was also amplified with *aadA* F/R AccI ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)). Both PCR products were purified and cut with the restriction endonuclease AccI and ligated together to produce pKNG-*antΔ* ([Table 1](#T1){ref-type="table"}). pKNG-*antΔ* was transformed into electrocompetent MC1061 lysogen cells carrying either of the prophages Φ24~B~::Kan and Φ24~B~::Cat ([Table 1](#T1){ref-type="table"}). All Sm^R^ resistant transformant colonies contained pKNG-*antΔ* integrated into Φ24~B~ *ant*, as confirmed by the absence of a PCR amplification product with Ant F/R primers and sensitivity to sucrose when subcultured on LB Agar plates in which NaCl was replaced with 10% (w/v) sucrose. Randomly selected colonies were passaged in LB broth without antibiotic selection, and 100 µl of mid-exponential culture was spread, daily, onto LB Sucrose Agar plates. Any colonies able to grow in the presence of sucrose had lost the integrated pKNG101 plasmid backbone, and the wild-type *ant* was replaced by *antΔaadA*, as confirmed by PCR (data not shown).

Luminescent reporter gene fusion construction
---------------------------------------------

The Φ24~B~ *pR′* promoter region was amplified from purified Φ24~B~ DNA using pStx F*/*R oligonucleotides ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)) and the *luxABCDE* operon was amplified from pSB2030 ([@B32]) using Lux F*/*R primers ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)). Both the promoter and *lux* operon were cut with the relevant restriction enzymes (PstI, SpeI and XhoI), while the medium copy number plasmid pACYC-Duet ([Table 1](#T1){ref-type="table"}) was cut with PstI and XhoI. Each of the above was agarose gel purified and recovered using the QIAquick gel extraction kit (Qiagen, Ltd). A single plasmid, pStxACYC, was constructed following ligation of the three products, ([Table 1](#T1){ref-type="table"}). pStxACYC was then transformed into competent MC1061/Φ24~B~::Kan or MC1061/Φ24~B~::Kan *antΔ* lysogen cells ([Table 1](#T1){ref-type="table"}); transformants were selected for on agar plates containing chloramphenicol (50 µg ml^−1^) and spectinomycin (100 µg ml^−1^). Complementation of *ant* was performed by amplifying the Φ24~B~ *ant* gene from purified bacteriophage Φ24~B~ DNA using Ant F*/*R oligonucleotides ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)). This product was agarose gel purified and cut with the restriction endonucleases NcoI and SalI, whilst the plasmid pBAD/*Myc*-His was cut with the same enzymes ([Table 1](#T1){ref-type="table"}). Both products were ligated together to create the antirepressor expression construct, pΦ24~B~-*ant* ([Table 1](#T1){ref-type="table"}). pΦ24~B~-*ant* was then transformed into competent Φ24~B~::Kan *antΔ* lysogen cells harboring pStxACYC.

Lux reporter gene assay
-----------------------

Fresh overnight cultures were used to inoculate 50 ml of LB broth; each culture was prepared in duplicate---one culture serving as a negative control and the other subjected to norfloxacin-based bacteriophage induction ([@B33]). Cultures were grown for ∼3 h to mid-exponential growth phase (OD~600~ = 0.5), at which point the antibiotic norfloxacin was added to the induced cultures at a working concentration of 1 µg ml^−1^. Triplicate 200 µl samples were taken immediately for luminescence and optical density measurements, in opaque and transparent 96-well plates, respectively, and analyzed in a VICTOR3 plate reader (PerkinElmer). This sampling regime was repeated at intervals of 30 min. Specific luminescence was calculated as luminescence per optical density unit.

Quantitative PCR
----------------

Single, double and triple lysogen cultures were harvested at an OD~600~ of 0.5. Total RNA was extracted using an RNeasy mini kit (Qiagen Ltd), according to the manufacturer\'s specifications. Genomic DNA contamination was removed with Ambion RNase-free DNase (Applied Biosystems) and RNA was quantified with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific Inc.). RNA (0.5 μg) for each reaction was transcribed into cDNA using RNaseH reverse transcriptase (Bioline Ltd) in a total of 20 μl. cDNA (1 μl) was then used as template for each qPCR reaction in Sensimix qPCR reaction mixture (Quantace Ltd). All experiments were designed to comply with the standard Sensimix cycling conditions with an annealing temperature of 60°C and an amplicon size of ∼100 bp. qPCR reactions were carried out using a Miniopticon thermal cycler (BioRad Labs Inc.). Integrase was amplified using *int* qPCR F/R, and the copy number was determined on a standard curve (copy number range = 5 × 10^3 ^− 5 × 10^8^), providing absolute quantification of the amplified products.

CI overexpression
-----------------

Φ24~B~ *cI* was amplified from bacteriophage Φ24~B~ DNA purified according to the method of Rooks *et al.* ([@B34]) using CI F/R oligonucleotides ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)), agarose gel purified and cut with NcoI and SalI restriction endonucleases; the plasmid pBAD/*Myc*-His was also cut with NcoI and SalI ([Table 1](#T1){ref-type="table"}). These products were ligated together to create pΦ24~B~-*cI* ([Table 1](#T1){ref-type="table"}). pΦ24~B~-*cI* was then transformed into competent *E. coli* lysogen cells \[strain MC1061 carrying the Φ24~B~::Kan prophage (MC1061/Φ24~B~::Kan)\], and transformants were selected for by resistance to the antibiotics kanamycin (50 μg ml^−1^) and ampicillin (100 μg ml^−1^). A MC1061/Φ24~B~::Kan culture carrying pΦ24~B~-*cI* was incubated at 37°C until it reached an OD~600~ of 0.5, and *cI* expression was induced through addition of arabinose to working concentrations of 0.2% (w/v), 0.002% (w/v) or 0% (negative control), before further incubation at 37°C for 2 h. Samples were taken post-induction and processed for qPCR, as above, and for SDS--PAGE analysis. Transcripts of the *cI*, *Q* and *int* genes were amplified with *cI* qPCR F/R, *Q* qPCR F/R and *int* qPCR F/R, respectively ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)); an endogenous reference, 16S rRNA processing gene *rimM*, was amplified with *16S* qPCR F/R ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)). Expression from test strains was quantified by the 2^−ΔΔ*C*~*T*~^ relative abundance method ([@B35]).

Rapid amplification of 5′-complementary DNA ends (5′-RACE)
----------------------------------------------------------

The lysogen MC1061/Φ24~B~::Kan was cultured at 37°C to an OD~600~ of 0.5. Total RNA was extracted using an RNeasy mini kit, and immediately processed with a 2nd generation 5′/3′-RACE kit (Roche Applied Science) according to manufacturer\'s instructions for 5′-amplification. DNA purification steps were carried out using the manufacturer\'s recommended High Pure PCR Product Purification Kit (Roche Applied Science), and the custom oligonucleotide primers Int RACE Sp3, Sp2 and Sp1 ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)) were used in conjunction with primers included in the 5′/3′-RACE kit for amplification of the 5′-integrase region. The resultant PCR amplification products were cloned into a ZeroBlunt vector (Invitrogen) and sequenced using standard M13 F/R primers (GATC-Biotech). The transcription start site was mapped onto the Φ24~B~ genome, and the promoter region and binding sites predicted *in silico*.

Integration/excision vector construction
----------------------------------------

The Φ24~B~ *int* and *attP* sites along with its primary bacterial *attB* site were amplified with Integrase F/R, attP F/R and attB F/R, respectively ([@B20]). The integrase gene and the two attachment sites were each cloned, separately, into ZeroBlunt cloning vector (Invitrogen), according to manufacturer\'s guidelines. The cloned fragments were subsequently excised using NcoI and KpnI, or BamHI and XhoI endonucleases for the integrase gene or both the attachment sites, respectively. Three plasmids with compatible origins of replication were also cut, pBAD/*Myc*-His C (NcoI and KpnI), pACYC-Duet and pCDF-Duet (BamHI and XhoI) ([Table 1](#T1){ref-type="table"}). After deactivation of the enzymes, the integrase gene was ligated into pBAD/*Myc*-His C to form pΦ24~B~-*int* ([Table 1](#T1){ref-type="table"}), *attB* was ligated into pACYC-Duet to form pΦ24~B~-*attB* ([Table 1](#T1){ref-type="table"}) and *attP* was ligated into pCDF-Duet to form pΦ24~B~-*attP* ([Table 1](#T1){ref-type="table"}).

Integration/excision assay
--------------------------

Various combinations of plasmid constructs in appropriate strains were produced as summarized in [Table 2](#T2){ref-type="table"}. Integration of pΦ24B-*attP* into pΦ24B-*attB* to create pΦ24B-*attLR* ([Table 1](#T1){ref-type="table"}) under different conditions was monitored qualitatively by plasmid purification using a Plasmid Miniprep kit (Qiagen) and visualization on a 0.7% (w/v) agarose gel and quantitatively by qPCR using linearized (digestion with either BglI or PciI) plasmids as templates with integration specific primers that spanned the crossover site \[Integ qPCR F/R ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1))\] as well as primers specific to the plasmid backbone \[Duet qPCR F/R ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1))\]. Integration and excision events were then compared by the relative abundance of the integrated amplification product (Integ qPCR F/R derived product) compared to the total plasmid copy number present (Duet qPCR F/R derived product). qPCR was carried out using a 7500 Fast qPCR system (Applied Biosystems) and Sensimix qPCR reagents (Quantace Ltd, see Quantitative PCR). Table 2.Integration/excision plasmid permutationsAssaypΦ24~B~-*attB*pΦ24~B~-*attP*pΦ24~B~-a*ttLR*pΦ24~B~-*int*pΦ24~B~-IXΦ24~B~1++−−−−2++−+−−3−−+−−−4−−++−−5−−+−+−6++−−−+7−−+−−+[^3]

Excisionase cloning and expression
----------------------------------

The putative excisionase was initially identified by a systematic *in silico* screening process, based solely on size and location of possible ORFs. All potential ORFs of 150--600 bp, within 5 kb of Φ24~B~ *int* and beginning with any of the *E. coli* alternate start codons \[ATG, GTG, TTG, ATT and CTG ([@B36])\], were analyzed. The candidate Xis was amplified from Φ24~B~ DNA using Xis F*/*R oligonucleotides ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)), purified and cut with the restriction endonucleases NcoI and BamHI. pACYC-Duet ([Table 1](#T1){ref-type="table"}) was also cut with the same enzymes, NcoI and BamHI. The two compatible DNA fragments were ligated together to produce pΦ24~B~-X ([Table 1](#T1){ref-type="table"}). pΦ24~B~-X was then used as a template for PCR amplification with T7 F/Xis R. The resulting PCR product, containing the T7 promoter from pACYC-Duet plus the putative Φ24~B~ *xis*, was cut with HindIII endonuclease and ligated into HindIII cut pΦ24~B~-*int* ([Table 1](#T1){ref-type="table"}) to create pΦ24~B~-IX ([Table 1](#T1){ref-type="table"}). pΦ24~B~-IX was transformed into BL21(AI) cells ([Table 1](#T1){ref-type="table"}) and transformants selected for by resistance to ampicillin (100 μg ml^−1^). Excisionase activity was monitored by agarose gel electrophoresis and qPCR (see Integration/excision assay).

Bioinformatics
--------------

Database searching was done with BLAST and PSI-BLAST ([@B37]) in the nr database ([@B38]). Domain searches were made in the databases CDD ([@B38]) and InterPro ([@B39]). More sensitive domain searching was done with HHpred ([@B40],[@B41]). In accord with the extreme sequence divergence exhibited by the Xis sequences, a structure-based alignment approach was employed. A structure alignment of members of Pfam ([@B42]) families Phage_AlpA \[PF05930; TorI with PDB ([@B43]) code 1zh4 ([@B44])\], Excisionase like \[PF07825; lambda phage Xis, 2ief ([@B27])\] and PF09035 \[Tn916-Xis; 1y6u ([@B45])\] was made with MUSTANG and STACCATO ([@B46]) and used, as the basis to unite three alignments using the program Jalview ([@B47]). Each of the three alignments, made with MUSCLE ([@B48]), contained Xis sequences bearing similarity to the respective Pfam families. Other Xis sequences, belonging to different Pfam families but recognizably distantly related to AlpA, were added to the aggregate alignment with the benefit of alignments deriving from the sensitive profile--profile matching program HHpred ([@B40],[@B41]). The resulting alignment was subject to phylogenetic analysis with MEGA 4 as follows ([@B49]). The bootstrap consensus tree inferred from 1000 replicates was taken to represent the evolutionary history of the taxa analyzed ([@B50]). The evolutionary distances were computed using the Poisson correction method ([@B51]) and the units are the number of amino acid substitutions per site. The ME tree was searched using the Close-Neighbor-Interchange (CNI) algorithm ([@B52]) at a search level of 1. The Neighbor-Joining algorithm ([@B53]) was used to generate the initial tree. All positions containing alignment gaps and missing data were eliminated only in pair-wise sequence comparisons.

Ten models of Φ24~B~ Xis were produced with MODELLER ([@B54]) using the structure of TorI \[PDB code 1zh4 ([@B44])\] as a template. The DOPE statistical potential ([@B55]) and stereochemical analysis ([@B56]) were used to select a model for further analysis. Electrostatic characteristics of the model were explored with APBS ([@B57]) and putative protein--protein interfaces sought with HotPatch ([@B58]). DNA-binding ability was tested with DB-MOM ([@B59]) and PRO-DNA ([@B60]). Further protein structure superpositions were done with SSM ([@B61]) and displayed in PyMOL ([@B62]), which was also used to produce structure figures.

RESULTS
=======

Characterization of the activity of ant
---------------------------------------

Previous studies have shown that the frequency of multiple lysogen formation, through sequential superinfection, exceeds the rate of single lysogen formation by infection of a naїve host ([@B19],[@B20]). This suggests that the incumbent prophage in some way aids the integration of the superinfecting bacteriophage, thus increasing integration efficiency. The presence ([Figure 1](#F1){ref-type="fig"}A) and expression of a putative antirepressor gene (*ant*) present in Φ24~B~ was postulated to be responsible for the phenomenon of multiple lysogeny through a mechanism of derepression ([@B20]). However, superinfection experiments using Φ24~B~ *antΔ* strains demonstrated that the lack of Ant failed to have any effect, positive or negative, on superinfection compared with wild-type Φ24~B~ (data not shown). Instead, further investigation has produced evidence of a likely role in assisting relief of CI repression during induction into the lytic cycle, consistent with independent observations reported for a similar antirepressor of bacteriophage 2851 ([@B63]). A pR′-*luxABCDE* fusion was used as a reporter for bacteriophage late gene expression following norfloxacin induction of lysis ([Figure 1](#F1){ref-type="fig"}B). Three different lysogen cultures were tested: Φ24~B~ wild-type, Φ24~B~ *antΔ* and Φ24~B~ *antΔ* complemented with pBAD-*ant*. Luminescence was measured over 4 h proceeding norfloxacin addition. The lag phase before substantial increases in pR′ expression were detectable was ∼120 min for each of the strains, and the difference between both the two test strains and the wild-type reference varied markedly from this time point onwards ([Figure 1](#F1){ref-type="fig"}C). The *antΔ* strain peaked at luminescence intensity up to 55.6% of the wild-type luminescence at 120 min, but decreased to 27.2--31.0% for the remainder of the experiment ([Figure 1](#F1){ref-type="fig"}C). In comparison, the complemented strain was able to restore 82.1% of wild-type luminescence levels at 120 min before decreasing to 64.3--65.3% and eventually returning to 79.5% after 240 min ([Figure 1](#F1){ref-type="fig"}C). Figure 1.Antirepressor Location and Function. (**A**) Transcription is indicated by arrows above or below the line with pR, pR′ and pRM promoters labeled adjacent to their transcription start sites. Gene names, indicated in italics, are transcribed leftward when below the line or rightward when above. The right operator region including the 3 CI binding sites (OR1-3) is annotated. The qut transcription termination site is represented by a raised triangle immediately after pR′. The putative antirepressor gene is located before this *qut* site and thus should be expressed shortly after induction to the lytic cycle, where it plays a role in accelerating phage derepression. Relief of CI mediated repression results in high level expression from pR′ leading irreversibly to lysis and release of Stx. (**B**) Map of the pR′ reporter gene fusion, including the *stxA* transcription start site. The pR′ promoter location and the *qut* transcription termination site are indicated. (**C**) Lux specific luminescence driven from the pR′ promoter during induction of phage lysis by addition of norfloxacin antibiotic. T~0~ is measured from the addition of inducing agent and there is a 90-120 min lag phase before expression increases appreciably. The three lines correspond to the antirepressor knock-out mutant (Δ, Ant−), the complemented strain (○, Ant+) and the wild-type control (□, WT). Error bars represent combined standard error for luminescence/optical density quotient (*n* = 3).

Uninduced integrase expression
------------------------------

Clearly, some factor outside the production of an antirepressor is involved in driving increased frequencies of lysogen formation upon superinfection. A potential mechanism to explain this observation would be expression of integrase from the resident integrated phage, which would more typically be strongly repressed by the lambdoid immunity system present in Stx-phages. Integrase transcript abundances were determined for single, double and triple lysogens of the Stx-phage by qPCR, in the absence of any stimulus for the lytic cycle. Expression of Φ24~B~ integrase increased 2.6-fold in the double lysogen and 7.5-fold in the triple lysogen, each compared to expression levels in the single lysogen ([Figure 2](#F2){ref-type="fig"}A). This observation suggests that integrase expression is not fully controlled by the global phage repressor protein, CI. Furthermore, complete genome sequence data for Φ24~B~ (Accession number: HM_208303) has revealed that the integrase gene is present in an inverted orientation ([Figure 3](#F3){ref-type="fig"}A) compared to other lambdoid phages such as lambda (NC_001416) and 933W (NC_000924). This inversion implies that its regulation must be different to these well-studied phages like Lambda phage where the *int* gene is subject to repression from CI. To identify whether the regulation of Φ24~B~ Int expression is uncoupled from CI repression, CI was overexpressed through arabinose induction ([Figure 2](#F2){ref-type="fig"}B) in a Φ24~B~ lysogen background, and the effect on integrase expression monitored by qPCR ([Figure 2](#F2){ref-type="fig"}C). As a control, expression of the *Q* antiterminator gene, the key regulator of the lytic cycle, was also monitored ([Figure 2](#F2){ref-type="fig"}C). As expected, integrase expression was not affected by increased levels of CI, whereas Q expression was significantly (*P* \< 0.05) decreased ([Figure 2](#F2){ref-type="fig"}B and C). The Φ24~B~ immunity region, whilst identical to bacteriophage 933W ([@B20],[@B64]), differs in organization from bacteriophage lambda in that there are only two left operator binding regions rather than three. This does not however compromise repression of transcription from the pL promoter or affect lysogen stability ([@B65],[@B66]). Bandshift analysis was carried out to confirm that the Φ24~B~ CI protein is able to effectively bind to the left operator region. Indeed, similar to 933W ([@B67]), binding occurred as expected (data not shown), and thus a defect in the immunity region is unlikely to be a factor in the phenomenon of multiple lysogeny. Figure 2.(**A**) Φ24~B~ integrase expression. Absolute qPCR quantification of integrase mRNA copy numbers in uninduced, mid-exponential growth phase single (1X), double (2X) and triple (3X) lysogen cultures. (**B**) Φ24~B~ CI overexpression. Relative qPCR quantification of Φ24~B~ *cI* repressor transcripts overexpressed from an *araBAD* promoter in the presence of increasing concentrations of arabinose from 0% to 0.2% (w/v), including an overlaid 12% SDS-PAGE gel confirmation of protein level overexpression. (**C**) Relative qPCR quantification of *Q* and *int.* Determination of the relative levels of expression of the Φ24~B~ lytic regulator *Q* (open bars) and *int* (closed bars) genes in the presence of arabinose-induced *CI* repressor. Figure 3.(**A**) Schematic map of the Φ24~B~ integrase region. This updated genetic map includes the integrase in an inverted orientation to the bacteriophage lambda model, and thus not under the control of CI through its indirect repression of *int* transcription from pL during lysogeny (as in lambda), and the novel excisionase ORF which would be under the auspices of CI via pL. The proposed pInt promoter is also indicated. (**B**) Schematic of the Φ24~B~ integrase transcription start site and predicted promoter as determined by 5′-RACE and *in silico* analysis. The poly-T start to the RACE output (5′-RACE) is an artifact of the amplification process; Φ24~B~ genome sequence (HM_208303) was used for the alignment. Putative -10/-35 promoter constituents and the distal portion of a putative UP-element are indicated by labeled solid lines and a dashed line, respectively. Transcription start is also indicated by asterisks along with the new putative translational start site hash and ribosomal binding site (RBS) along with the previous, discredited translational start site (X). (**C**) Expression of Φ24~B~ integrase from an *araBAD* inducible promoter with increasing levels of arabinose, shown by 10% SDS--PAGE.

5′-RACE determination of integrase start site
---------------------------------------------

Φ24~B~ encodes a novel integrase, as yet uncharacterized, which is extremely promiscuous with regard to integration site selection ([@B20]). Furthermore, there was no obvious gene encoding an excisionase-like protein identifiable anywhere on the bacteriophage chromosome (HM_208303), including the areas immediately up- and down stream of the *int* gene. An integrase capable of performing both excision and integration functions has been described in association with an *E. coli* pathogenicity island ([@B31]), but never in association with an inducible bacteriophage, lambdoid or otherwise. *In silico* analysis predicted a 1245 bp integrase-encoding ORF in the Φ24~B~ genome, and this was cloned into a pBAD expression vector (Invitrogen). However, we failed to successfully express the integrase protein after repeated attempts (data not shown). We therefore set out to establish the transcription and translation start sites, and determine whether these were compatible with the *in silico* predictions. To resolve the transcriptional start site, rapid amplification of the 5′-complementary DNA end (5′-RACE, Roche) was performed. The cDNA end product was sequenced and revealed that transcription actually initiates 46-bp downstream of the expected translational start codon ([Figure 3](#F3){ref-type="fig"}B). From this information, the promoter elements were predicted using the BDGP neural network promoter predictor ([@B68]) and a potential UP-transcription activation element was mapped by comparison to published sequences ([@B69],[@B70]). UP elements are short stretches of AT-rich sequence present in some promoters, directly upstream of the core region. These elements enhance transcription by interacting with RNA polymerase, though they are not essential for overall promoter function ([@B69; @B70; @B71]). The Φ24~B~ integrase promoter (*pInt*) contains a match to only the distal section of the UP element consensus sequence (9 out of 11 bases) and the proximal section is absent, however, 'half sites' have previously been shown to be functional ([@B72]). Improved promoter and transcriptional start data also assisted in the production of a new *int* ORF prediction using the FrameD online 'Gene Finder' tool (<http://bioinfo.genotoul.fr/apps/FrameD/FD>) ([@B73]). This updated ORF utilizes the rare TTG start codon and experimentally facilitated Int expression from an inducible promoter ([Figure 3](#F3){ref-type="fig"}C) ([@B73]).

Integration excision system: integrase inability to catalyze excision
---------------------------------------------------------------------

In order to test Int function experimentally, a three-plasmid system was used in which the Φ24~B~ *attP* site, bacterial *attB* site and the Φ24~B~ integrase were each cloned separately into compatible, low copy number plasmids. Integration and excision events could then be detected by determining the presence of either a large pΦ24~B~-*attLR* integrated plasmid or individual, resolved pΦ24~B~-*attB/attP* containing plasmids ([Figure 4](#F4){ref-type="fig"}A), and these could be quantitated further by qPCR. By this method, we were able to demonstrate integrative function for the expressed integrase protein alone, in the absence of any other accessory phage proteins ([Table 2](#T2){ref-type="table"} and [Figure 4](#F4){ref-type="fig"}B). Moreover, efficient integration of the plasmids was also observed when transformed into a single lysogen host in the absence of any stimulus for integrase production ([Figure 4](#F4){ref-type="fig"}B). This latter observation further corroborates the hypothesis set out earlier that integrase is expressed in a lysogen, uncoupled from CI mediated repression, and that this may help to assist in the integration of superinfecting bacteriophage. All attempts to resolve the integrated pΦ24~B~-*attLR* plasmid into its two component plasmids with the integrase expression construct present, alone, were futile ([Table 2](#T2){ref-type="table"}, assay 4; data not shown), whilst resolution of pΦ24~B~-*attLR* within in a lysogen was easily detectable when that lysogen was subjected to norfloxacin induction (data not shown), but not detectable, even by qPCR, in an uninduced lysogen ([Table 2](#T2){ref-type="table"}, assay 7). These experiments indicated that there must be a phage-encoded accessory factor that remained coupled to CI repression and the standard lambdoid regulatory cascade that is essential for Φ24~B~ prophage excision. Figure 4.Plasmid integration/excision assay. (**A**) Schematic representation of the component plasmids bearing the Φ24~B~ attachment sites (pΦ24~B~-*attB* and pΦ24~B~*-attP*) and the combined integrant resulting from integrase mediated, site-directed recombination (pΦ24~B~-*attLR*). qPCR primer binding sites are highlighted on the integrated pΦ24~B~-*attLR* plasmid. (**B**) Agarose gel electrophoresis of purified plasmids harvested following the *in situ* integration or excision assays. The panels correspond to: (**I**) plasmid integration in the presence of a Φ24~B~ lysogen ([Table 2](#T2){ref-type="table"}, assay 6); (**II**) integrase expressed from an inducible promoter ([Table 2](#T2){ref-type="table"}, assay2); (**M**) Bioline Hyperladder I is included as a size reference; (**III**) excision control without integrase or excisionase ([Table 2](#T2){ref-type="table"}, assay 5, no arabinose); (**IV** and **V)** integrase plus excisionase ([Table 2](#T2){ref-type="table"}, assay 5, with arabinose). Arrows indicate the position for the plasmids: (**LR)** integrated pΦ24~B~-*attLR* plasmid; (**Int**) pΦ24~B~-*int*; and (**U)** the similarly sized plasmids pΦ24~B~-*attB* and/or pΦ24~B~-*attP*. All plasmids were linearized with BglI endonuclease, except where marked by asterisks in lane **V**, which contains supercoiled plasmid DNA. Complete degradation of excised plasmids after attempted linearization is shown in panel **IV**.

Identification and bioinformatic analysis of a putative excisionase
-------------------------------------------------------------------

The small size of the majority of currently described excisionases (typically more than 100 amino acids) limits the ability to predict and identify novel excisionase proteins based on homology searches ([@B28]). Excisionase genes are usually found in close proximity to their cognate *int* ([@B74],[@B75]), therefore, due to the location and orientation of Φ24~B~ *int*, it was predicted that the excisionase gene was likely to be situated adjacent to the 3′ of the integrase. In addition, although *E. coli* primarily utilizes ATG as a translation start codon (83% of genes in *E. coli* K-12), several other codons can also be used such as GTG (14%) and TTG (3%) as well as the rare ATT and CTG codons ([@B36]). Bearing this information in mind, investigation of all possible short ORFs in the proximity of the integrase gene identified only one candidate ORF, which was predicted to encode an 8 kDa protein. Database searches by BLAST and PSI-BLAST revealed only four close homologs from *E. coli* strains, none of which had been experimentally determined to possess an excisionase function. Similarly, searches of domain databases CDD and InterPro with default parameters failed to place the candidate protein sequence in any known protein family. Nevertheless, analysis with HHpred, a more sensitive sequence comparison method, revealed a clear but distant relationship between the candidate ORF and Pfam family phage_AlpA (PF05930). The *e*-value was 5 × 10^−6^, and the alignment between the ORF and the domain consensus produced 40% sequence identity, although the alignment only covered 47 residues of the candidate ORF. This provided a strong indication that the candidate ORF indeed encoded a Xis protein since several characterized Xis/RDF proteins belong to this family e.g. *E. coli* TorI ([@B76]), and the Xis proteins from *E. coli* phage Phi80 ([@B77]) and *Shigella flexneri* ([@B78]).

An alignment was made of Φ24~B~ Xis with other experimentally demonstrated or reliably predicted excisionase sequences, building on earlier lists ([@B28],[@B78]). Extreme sequence diversity has often left doubts over the true homology of some excisionases ([@B28]), and the alignment was therefore limited to sequences with demonstrable homology, using sensitive profile--profile matching ([@B40],[@B41]) to winged-helix excisionases such as lambda Xis and TorI. As well as phage_AlpA, these sequences belonged to, or resembled, several Pfam families: Excisionase like \[PF07825; e.g. lambda phage Xis ([@B27])\], Tn916-Xis \[PF09035 ([@B45])\], Putative excisionase \[PF06806 ([@B64])\] and Regulatory phage protein Cox \[PF10743 ([@B79])\]. Alignment ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)) of these sequences illustrated the extreme sequence diversity of excisionases with this architecture. Even within the common helix-turn-helix motif and the shared small 'wing' β-sheet sequence, conservation is very limited, and many members have N- or C-terminal extensions. This diversity is responsible for the difficulty previously encountered ([@B28]) and seen again in this work, of annotating excisionase proteins using conventional bioinformatic tools. Bootstrapped phylogenetic analysis of the alignment ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)) revealed few strongly supported nodes, unsurprising in view of the diversity of the sequences. In particular, Φ24~B~ Xis clustered reliably only with an unpublished, unannotated sequence from Stx2-converting Φ86 phage (Accession number: AB255436) from *E. coli* O86. This phage is a close relative of Φ24~B~ and its almost identical integrase shares the inverse orientation, in contrast, to most characterized lambdoid phages.

Experimental validation of excisionase function
-----------------------------------------------

Excisionase function was confirmed experimentally for the newly identified Φ24~B~ *xis* ORF by co-expression with Φ24~B~ *int* from a single expression plasmid construct, pΦ24~B~*-*IX, in the presence of the integrated pΦ24~B~*-attLR* plasmid *in situ* ([Figure 4](#F4){ref-type="fig"}). The co-expressed proteins were able to effectively resolve pΦ24~B~*-attLR* into its constituent plasmids, resulting in cells harboring the expression construct plus the plasmids pΦ24~B~*-attB* and pΦ24~B~*-attP*, as observed by agarose gel electrophoresis ([Figure 4](#F4){ref-type="fig"}B). Some residual pΦ24~B~*-attLR* remained in these cultures, though in lower quantities than the resolved plasmids. To obtain a quantitative measure of the efficiency of these reactions, an absolute qPCR method was devised to enumerate the levels of integrated pΦ24~B~*-attLR* plasmid compared to individual component plasmids ([Figure 4](#F4){ref-type="fig"}A). Integration and excision reactions were consistently efficient and indisputably substantiate the claim that the proposed Φ24~B~ integrase and excisionase do indeed function as predicted ([Figure 5](#F5){ref-type="fig"}). Figure 5.qPCR quantification of integration/excision. Proportion of total plasmids present that are in the integrated state (pΦ24~B~-*attLR*): (+ve) agarose gel purified pΦ24~B~-*attLR*; (−ve) pΦ24~B~-*attB* and pΦ24~B~*-attP* in the absence of either a phage or plasmid borne integrase; (Int) pΦ24~B~-*attB* and pΦ24~B~*-attP* in the presence of expressed Φ24~B~ integrase ([Table 2](#T2){ref-type="table"}, assay2 with arabinose); (**A--C**) pΦ24~B~-*attLR* in the presence of co-expressed arabinose-inducible Φ24~B~ integrase and excisionase at arabinose concentrations (w/v) of 0%, 0.002 and 0.2%, respectively ([Table 2](#T2){ref-type="table"}, assay5).

A molecular model of Φ24~B~ Xis
-------------------------------

The structure of *E. coli* TorI ([@B44]) was used as a template to model Φ24~B~ Xis. Although the HHpred-derived alignment matched only 15% of residues between the two proteins, modeling was facilitated by the existence of only a single one-residue deletion in Φ24~B~ Xis compared to TorI, which could be readily structurally accommodated. Ten models were constructed with MODELLER ([@B54]) and that with the best DOPE score ([@B55]) selected. The chosen model also had good stereochemical qualities including 87% of residues in core areas of the Ramachandran plot ([@B56]). The C-terminal seven residues of Φ24~B~ Xis could not be modeled since they were not aligned with template by HHpred and are likely to adopt a different conformation: no regular secondary structure for this region is predicted in Φ24~B~ Xis, but the corresponding part of TorI is α-helical.

DNA-binding proteins often have a large positively charged, surface and we sought this feature on the Φ24~B~ Xis model. Indeed, one face of the Xis protein bears a pronounced positive charge ([Figure 6](#F6){ref-type="fig"}A). This corresponds to the side of the protein structure that binds DNA in the lambda phage Xis crystal structure ([Figure 6](#F6){ref-type="fig"}C) ([@B27]), which has been implicated by site-directed mutagenesis in DNA binding of TorI ([@B44]). Figure 6.Electrostatic analysis of protein structures. The three structurally superimposed structures shown are (**A**) Φ24~B~ Xis model, (**B**) TorI ([@B44]) and (**C**) lambda Xis in complex with DNA ([@B27]). Solvent-accessible surfaces are colored blue (positive) to red (negative). Calculations were done with APBS ([@B57]).

In view of the capacity of some Xis proteins---demonstrated or predicted ([@B27])---to self-interact and form DNA-bound micronucleoprotein filaments, potential sites of protein--protein interaction on the Φ24~B~ Xis model were sought with HotPatch ([@B58]). For protein--protein interactions, exposed hydrophobic residues constitute the most reliable predictor of interaction sites. The model of Φ24~B~ Xis produces a single, strong prediction comprising four solvent-exposed hydrophobic residues in close proximity---Phe31, Pro32, Val35 and Leu36 ([Figure 7](#F7){ref-type="fig"}). Figure 7.Comparison of lambda phage Xis micronucleoprotein filament-like DNA-bound structure and a hypothetical Φ24~B~ Xis model structure. (**A**) Adjacent subunits of the lambda phage Xis micronucleoprotein filament ([@B27]) with an interface loop highlighted with Arg13 and Arg14 side chains. (**B**) The selected model is superimposed on the same lambda phage Xis subunits. The lower subunit is coloured in a spectrum from blue N-terminus to red (incomplete) C-terminus. The upper subunit is shown as cartoon and semi-transparent molecular surface and is colored as gray except for the four exposed hydrophobic residues---Phe31, Pro32, Val35 and Leu36---highlighted by HotPatch ([@B58]) as a possible protein--protein interaction site which are colored red. The very C-terminal residues of Φ24~B~ Xis, not included in the model, could interact with that putative interaction site.

DISCUSSION
==========

Previous examination of the Φ24~B~ genome sequence revealed the presence of a putative antirepressor gene possessing 37% amino acid identity to the well-characterized P22 antirepressor, Ant (Accession number: NP_059643) ([@B20],[@B25]). It was also demonstrated qualitatively that the *ant* gene was expressed at very low levels in a quiescent lysogen culture ([@B20]). Alignment of the putative Φ24~B~ antirepressor protein with its P22 counterpart revealed significant sequence similarity primarily in the C-terminal domains (82% identity for the final 104 C-terminal residues). When expressed, P22 Ant is able to inactivate the phage repressor protein, analogous to the lambda CI repressor. This observation and the fact that we could measure expression of *ant* in the lysogen ([@B20]) led to speculation that Φ24~B~ Ant could alleviate CI repression sufficiently to allow superinfecting phages to integrate. However, the data presented here refute this hypothesis. No significant effect was observed on lysogen formation rates, either when superinfecting an isogenic *ant-*strain or when Ant was expressed from a plasmid in the host cells undergoing superinfection. On the other hand, when an *ant-*lysogen strain was induced into the lytic life cycle it was unable to effectively upregulate expression from the pR′ late genes promoter, in contrast to the wild-type with monitoring by bioluminescence assay ([Figure 1](#F1){ref-type="fig"}C). Expression of Ant during induction almost completely complemented wild-type induction levels. Hence, it seems that although Φ24~B~ Ant may well, but not necessarily, act on CI thus leading to its deactivation/inhibition, the role of Ant in the phage life cycle is not associated with multiple lysogeny but rather the acceleration of derepression during lytic induction ([Figure 1](#F1){ref-type="fig"}C).

The confirmed ability of the lambdoid phage Φ24~B~ to form multiple lysogens, following sequential infection of a single host ([@B18],[@B20]), directly contradicts predictions based upon the well-characterized lambda immunity model, despite the presence in Φ24~B~ of an apparently intact lambda-like immunity region with equivalent repressor binding affinities ([@B66],[@B67],[@B80]). Here, we present data which reveal the mechanism by which Φ24~B~ is able to circumvent superinfection immunity and, more importantly, actively promote the incorporation of multiple prophages following primary infection ([@B20]). The Φ24~B~ model hinges on the discovery, from the annotated genome sequence (HM_208303), that the integrase gene is transcribed in an inverted orientation relative to λ ([Figure 3](#F3){ref-type="fig"}A) ([@B15]) This fact, in conjunction with the discovery and characterization of a novel excisionase oriented in the same direction as λ *xis* ([Figure 3](#F3){ref-type="fig"}A), allows us to predict the chain of events that occurs during superinfection. Integrase production is not repressed by the phage global repressor, CI ([Figure 2](#F2){ref-type="fig"}) nor coupled to the lambdoid phage gene regulatory networks, but rather its expression is allowed to continue during stable lysogeny ([Figure 2](#F2){ref-type="fig"}), presumably leading to an intracellular build up of Int. It is the accumulation of integrase in the cytoplasm, in conjunction with the lack of repression of incoming isogenic phage integrase production, which most likely accounts for the increased frequency of lysogen formation during superinfection compared to infection of a naїve host ([@B20]). Furthermore, as the excisionase is not produced from the *pInt~24B~* promoter, Φ24~B~ is able to maintain a state of stable lysogeny despite the constitutive expression of *int*, as *xis* expression is linked to a standard lambda prophage induction pathway. This is exemplified by the almost complete conversion of plasmids bearing *attP* and *attB* to the integrated form ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}), when propagated in an uninduced Φ24~B~ lysogen. In summary, the evidence presented points to a clear mechanism for Φ24~B~ multiple lysogen production at a high rate, due to the fact that integrase is outside the control of global phage repression, however, prophage stability is maintained due to the orientation and lambdoid genetic regulatory strategy which leaves *xis* coupled to CI repressor control.

Identification of the Φ24~B~ excisionase was a non-trivial task as, despite careful investigation of the Φ24~B~ genome sequence, we were unable to identify any candidate ORFs likely to encode an excisionase gene in the expected area, and Blastn searches of the sequences surrounding the *int* gene against the non-redundant databases failed to elucidate any possible Xis coding sequences. This led us to consider the possibility that there may be no such gene present in the phage genome. Although there have been no reported cases of infective bacteriophages able to catalyze integration and excision with an integrase alone, such a situation has been described for a uropathogenic *E. coli* pathogenicity island ([@B30],[@B31]). However, in light of the fact that resolution of pΦ24~B~-*attLR* to its constituent plasmids was not possible when integrase alone was expressed from an inducible plasmid while excision events were detected when the Φ24~B~ prophage was present, a systematic location-targeted strategy was successfully employed. Distant homology of the candidate Xis protein sequence with the Phage_AlpA family, already containing several known excisionases, bore out our initial suspicions based on its genomic context. A molecular model confirmed that Φ24~B~ Xis protein adopts a winged-helix fold.

Interestingly, excisionase proteins with the winged-helix fold appear to function in diverse ways. In the archetypal Lambda phage Xis, from Pfam family 'Excisionase-like', binds directly to DNA, forming a micronucleoprotein filament which bends the DNA duplex in a way predicted to facilitate the excision process ([@B27]). Data suggest that the Tn916 Xis may function similarly ([@B27]). *Escherichia coli* TorI, from Pfam family phage_AlpA acts as a response regulator inhibitor, binding not only to DNA ([@B44]) but also to the DNA-binding domain of the TorR protein ([@B76]). Although this protein--protein interaction does not affect the DNA-binding capacity of TorR, it is thought to impede recruitment of RNA polymerase to the *torC* promoter. Finally, the AlpA protein acts as a transcription factor for the *int* gene of the phage CP4-57 in *E. coli* K-12 ([@B81],[@B82]), thereby affecting excision by a third variant mechanism.

DNA binding is a common feature of all these excisionases, and so it is no surprise that the model of Φ24~B~ Xis bears a characteristic positively charged surface ([Figure 6](#F6){ref-type="fig"}). Structure-based predictors of DNA-binding capacity---DB-MOM ([@B59]) and PRO-DNA ([@B60])---confirm that Φ24~B~ Xis should bind DNA. Attempts to predict further details of the molecular mechanism of Φ24~B~ Xis by phylogenomic analysis failed since bootstrapped trees did not reliably group this Xis with other experimentally studied excisionases ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq923/DC1)). However, the Φ24~B~ Xis model allowed us to address one aspect of function, namely the ability to form micronucleoprotein filaments. Inspection of the structure of phage lambda micronucleoprotein filament structure ([Figure 7](#F7){ref-type="fig"}A) highlights the role of the loop containing Arg13 and Arg14 in forming inter-subunit contacts. The corresponding loops in Φ24~B~ Xis ([Figure 7](#F7){ref-type="fig"}B) and Tn916 Xis (not shown) are shorter and, without significant rearrangement, appear to be too short to form similar interactions. However, seven residues at the C-terminus of Φ24~B~ Xis could not be modeled since they did not align reliably with the template. Intriguingly, the C-terminus of the incomplete model clearly shows that the missing residues could interact with the neighboring subunit at exactly the region picked out as a potential protein--protein interaction site. DNA purified from cells expressing Φ24~B~ Xis could not be cut with restriction endonucleases without a significant degradation of DNA: no bands were seen on subsequent agarose gels, only smearing ([Figure 4](#F4){ref-type="fig"}B). This observation offers circumstantial support for the notion that Φ24~B~ Xis binds DNA as micronucleoprotein filaments thereby destabilizing the duplex structure and increasing its susceptibility to degradation.
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[^3]: A summary of the various combinations of plasmids used for recombination assays to assess the function Φ24~B~ integrase and excisionase. All of the assays summarised above were carried out in *recA*^−^ *E. coli* hosts. Plasmid components (**pΦ24~B~-*attB*, pΦ24~B~-*attP*, pΦ24~B~-*attLR*, pΦ24~B~-*int* and pΦ24~B~-IX**) are described in [Table 1](#T1){ref-type="table"}, whilst the final column refers to presence/absence of a **Φ24~B~** prophage. For all of the assays, cells carrying the plasmids detailed were grown to mid-logarithmic growth phase (OD~600~:0.5) with the appropriate antibiotic selection. Plasmids from **1**, **3** and **6** were immediately purified with a Plasmid Miniprep kit (Qiagen Ltd). Cultures **2** and **4** were induced with arabinose, whilst **5** was induced with arabinose \[0, 0.2 and 0.02 (w/v)\] and IPTG (1 mM), each for 2 h, before plasmids were purified. Culture **7** was induced to produce native excisionase by addition of 1 μg ml^−1^ norfloxacin for 2 h, prior to plasmid purification.
